Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 176-185

  Segev Amzaleg, Niva ^a   Trudler, Dorit ^a   Frenkel, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Astroglia; IL 10; Nrf 2; Oxidative stress; PKC; Precondition; Stroke

Indexed keywords

INTERLEUKIN 10; PROTEIN KINASE C; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASTROCYTES; BRAIN; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; HEME OXYGENASE-1; INTERLEUKIN-10; MALE; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS;

EID: 84876816975     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.12.016     Document Type: Article

References (55)

1. Avni D., Ernst O., Philosoph A., Zor T. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol. Immunol. 2010, 47:1396-1403.
2. Beit-Yannai E., Trembovler V., Horowitz M., Lazarovici P., Kohen R., Shohami E. Neuroprotection against oxidative stress by serum from heat acclimated rats. Neurosci. Lett. 1998, 254:89-92.
3. Bell K.F., Al-Mubarak B., Fowler J.H., Baxter P.S., Gupta K., Tsujita T., Chowdhry S., Patani R., Chandran S., Horsburgh K., et al. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl. Acad. Sci. USA 2011, 108:E1-E2. author reply E3-E4.
4. Brenner S., Prosch S., Schenke-Layland K., Riese U., Gausmann U., Platzer C. CAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 2003, 278:5597-5604.
5. Brightbill H.D., Plevy S.E., Modlin R.L., Smale S.T. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 2000, 164:1940-1951.
6. Calkins M.J., et al. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signal. 2009, 11:497-508.
7. Cardona A.E., Huang D., Sasse M.E., Ransohoff R.M. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 2006, 1:1947-1951.
8. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 2002, 21:2-14.
9. Cohen S.B., Parry S.L., Feldmann M., Foxwell B. Autocrine and paracrine regulation of human T cell IL-10 production. J. Immunol. 1997, 158:5596-5602.
10. del Zoppo G.J., Becker K.J., Hallenbeck J.M. Inflammation after stroke: is it harmful?. Arch. Neurol. 2001, 58:669-672.
11. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 1996, 16:2553-2562.
12. Dietrich W.D., Busto R., Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 1999, 158:444-450.
13. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
14. Dobkin-Bekman M., Rahamin-Ben Navi L., Shterntal B., Sviridonov L., Przedecki F., Naidich-Exler M., Brodie C., Seger R., Naor Z. Differential role of PKC isoforms in GnRH and phorbol 12-myristate 13-acetate activation of extracellular signal-regulated kinase and Jun N-terminal kinase. Endocrinology 2010, 151:4894-4907.
15. Durukan A., Tatlisumak T. Preconditioning-induced ischemic tolerance. a window into endogenous gearing for cerebroprotection. Exp. Trans. Stroke Med. 2010, 2:2.
16. Escartin C., Bonvento G. Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 2008, 38:231-241.
17. Farfara D., Trudler D., Segev-Amzaleg N., Galron R., Stein R., Frenkel D. Gamma-Secretase component presenilin is important for microglia beta-amyloid clearance. Ann. Neurol. 2011, 69:170-180.
18. Frenkel D., Huang Z., Maron R., Koldzic D.N., Hancock W.W., Moskowitz M.A., Weiner H.L. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J. Immunol. 2003, 171:6549-6555.
19. Glantz L., Avramovich A., Trembovler V., Gurvitz V., Kohen R., Eidelman L.A., Shohami E. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp. Neurol. 2005, 192:117-124.
20. Haskew-Layton R.E., Payappilly J.B., Smirnova N.A., Ma T.C., Chan K.K., Murphy T.H., Guo H., Langley B., Sultana R., Butterfield D.A., et al. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc. Natl. Acad. Sci. USA 2010, 107:17385-17390.
21. Hinkle J.L., Bawman L. Neuroprotection for ischemic stroke. J. Neurosci. Nurs. 2003, 35:114-118.
22. Hughes-Fulford M., Sugano E., Schopper T., Li C.F., Boonyaratanakornkit J.B., Cogoli A. Early immune response and regulation of IL-2 receptor subunits. Cell Signal. 2005, 17:1111-1124.
23. Iadecola C., Anrather J. Stroke research at a crossroad: asking the brain for directions. Nat. Neurosci. 2011, 14:1363-1368.
24. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 2000, 275:16023-16029.
25. Jin R., Yang G., Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 2010, 87:779-789.
26. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
27. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 2003, 278:12029-12038.
28. Lifshitz V., Weiss R., Benromano T., Kfir E., Blumenfeld-Katzir T., Tempel-Brami C., Assaf Y., Xia W., Wyss-Coray T., Weiner H.L., et al. Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model. Neurobiol. Aging 2012, 33. 432 e401-432 e413.
29. Linker R.A., Lee D.H., Ryan S., van Dam A.M., Conrad R., Bista P., Zeng W., Hronowsky X., Buko A., Chollate S., et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain: J. Neurol 2011, 134:678-692.
30. Liu H.T., Tashmukhamedov B.A., Inoue H., Okada Y., Sabirov R.Z. Roles of two types of anion channels in glutamate release from mouse astrocytes under ischemic or osmotic stress. Glia 2006, 54:343-357.
31. Liu J., Ginis I., Spatz M., Hallenbeck J.M. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am. J. Physiol. Cell Physiol. 2000, 278:C144-153.
32. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988, 2:2557-2568.
33. Moran L.K., Gutteridge J.M., Quinlan G.J. Thiols in cellular redox signalling and control. Curr. Med. Chem. 2001, 8:763-772.
34. Moskowitz M.A., Waeber C. Remote ischemic preconditioning: making the brain more tolerant, safely and inexpensively. Circulation 2011, 123:709-711.
35. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.
36. Pinteaux E., Rothwell N.J., Boutin H. Neuroprotective action of endogenous Interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 2006, 53:551-556.
37. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006, 86:583-650.
38. Sarady-Andrews J.K., Liu F., Gallo D., Nakao A., Overhaus M., Ollinger R., Choi A.M., Otterbein L.E. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L1131-L1137.
39. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
40. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci. Lett. 2005, 377:206-211.
41. Segev-Amzaleg N., Benbenishty A., Frenkel D. Astrocytes are key players in mediating recovery following ischemic stroke. Adapt. Biol. Med. 2012, 7.
42. Shih A.Y., Li P., Murphy T.H. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 2005, 25:10321-10335.
43. Sims J.E., March C.J., Cosman D., Widmer M.B., MacDonald H.R., MacMahan C.J., Grubin C.E., Wignall J.M., Jackson J.L., Call S.M. CDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988, 241:585-589.
44. Soares M.P., Seldon M.P., Gregoire I.P., Vassilevskaia T., Berberat P.O., Yu J., Tsui T.Y., Bach F.H. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J. Immunol. 2004, 172:3553-3563.
45. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
46. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 1998, 251:189-192.
47. Takahashi T., Shimizu H., Morimatsu H., Inoue K., Akagi R., Morita K., Sassa S. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev. Med. Chem. 2007, 7:745-753.
48. Tone M., Powell M.J., Tone Y., Thompson S.A., Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 2000, 165:286-291.
49. Weiss R., Lifshitz V., Frenkel D. TGF-beta1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis. Brain Behav. Immun. 2011, 25:1017-1024.
50. Wen A.Y., Sakamoto K.M., Miller L.S. The role of the transcription factor CREB in immune function. J. Immunol. 2010, 185:6413-6419.
51. Yamashita K., McDaid J., Ollinger R., Tsui T.Y., Berberat P.O., Usheva A., Csizmadia E., Smith R.N., Soares M.P., Bach F.H. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J. 2004, 18:765-767.
52. Yamazaki S., Onishi E., Enami K., Natori K., Kohase M., Sakamoto H., Tanouchi M., Hayashi H. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Jpn. J. Med. Sci. Biol. 1986, 39:105-118.
53. Yu C.T., Shih H.M., Lai M.Z. Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation. J. Immunol. 2001, 166:284-292.
54. Zhang Y., Barres B.A. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr. Opin. Neurobiol. 2010, 20:588-594.
55. Ziegler-Heitbrock L., Lotzerich M., Schaefer A., Werner T., Frankenberger M., Benkhart E. IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. J. Immunol. 2003, 171:285-290.